Clinical trial

Immunization With NY-ESO-1 Protein Combined With CpG 7909 in Patients With Prostate Cancer

NCT00292045

Study summary

ClinicalTrials.gov

Immunization With NY-ESO-1 Protein Combined With CpG 7909 in Patients With Prostate Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

BIOLOGICAL · Unmapped registry intervention NY-ESO-1 protein/CpG 7909 Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-10-27

PhasePHASE1

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

NY-ESO-1 protein/CpG 7909BIOLOGICAL

Sponsors & collaborators

Ludwig Institute for Cancer Researchlead sponsor

Mapped research locations

FrankfurtGermany1 ZurichSwitzerland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00292045 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.